Empagliflozin and linagliptin and Novoeight
Determining the interaction of Empagliflozin and linagliptin and Novoeight and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and linagliptin-Novoeight recombinant
- Empagliflozin and linagliptin-Novolin 70/30
- Empagliflozin and linagliptin-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Empagliflozin and linagliptin-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Empagliflozin and linagliptin-Novolin N
- Empagliflozin and linagliptin-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Novoeight-Empagliflozin and metformin
- Novoeight-Empagliflozin and Metformin Extended-Release Tablets
- Novoeight-Empagliflozin and Metformin Tablets
- Novoeight-Empliciti
- Novoeight-Emsam
- Novoeight-Emsam Transdermal